• Home
• About Me
• Contact Me
• Archives
• Free-CE Links
• Pharmacy Blogs
• Terms of Use

Subscribe

• Drug Topics
• FDA: MedWatch
• FDA: News/Recalls
• Medical News
• Pharmacist News
• PharmAZy News

Preventing Medical Errors: Remembering to Re-Activate a Patients?s Defibrillator

A recent FDA article in the journal "Nursing2008" describes the case of a patient who died, possibly of ventricular fibrillation, following elective surgery. This happened because after the procedure, his implantable cardioverter defibrillator (ICD)...

Recalls and Safety Alerts: New Data on Thromboembolic Events with Ortho Evra Contraceptive Patch

The prescribing information for the Ortho Evra Contraceptive Transdermal Patch is being updated with results of a new study on the risk of venous thromboembolism. This study found that women aged 15-44 who used the birth control patch were at higher...

Recalls and Safety Alerts: Early Communication on Adverse Events from Botox and Myobloc

FDA has issued an early communication about serious adverse events, including respiratory failure and death, from Botox and Botox Cosmetic (Botulinum toxin Type A), and Myobloc (Botulinum toxin Type B). These events were related to how the product w...

Recalls and Safety Alerts: New Safety Warnings about Chantix

FDA is alerting healthcare professionals about new safety warnings for Chantix (varenicline), a drug used to help people stop smoking. Chantix has been linked to serious neuropsychiatric problems, including changes in behavior, agitation, depres...

Recalls and Safety Alerts: Fentanyl (Duragesic) Patches Recalled

Several brands of fentanyl transdermal patches are being recalled because they may have defects that could allow the fentanyl gel to leak out of the patch. If the gel touches patient's or caregiver's skin, it could cause respiratory depression and p...

New Medical Products: Decellularized Allograft Heart Valve Approved

FDA has cleared for marketing the first allograft heart valve from which cells and cellular debris have been removed. It is called the CryoValve SynerGraft Pulmonary Heart Valve, and is manufactured by CryoLife, Inc. Allograft valves are recove...

ACC: Senate Probe Finds Evidence that Drug Firms Worked to Delay ENHANCE Results

CHICAGO -- E-mails made public today described outrage more than a year ago by the ENHANCE trial's principal investigator because he perceived that a drugmaker was withholding bad results about ezetimibe/simvastatin (Vytorin) for non-scientific reasons.

ACC: Senate Probe Finds Evidence that Drug Firms Worked to Delay ENHANCE Results

CHICAGO -- Emails made public today described outrage more than a year ago by the ENHANCE trial's principal investigator because he perceived that a drugmaker was withholding bad results about ezetimibe/simvastatin (Vytorin) for non-scientific reasons.

ACC Monday Highlights: Hypertension, Lipids, and More

CHICAGO, March 31 -- MedPage Today reporters discuss the highlights of the day and touch on news that will be coming soon.

ACC: Octogenarian and Older Derive Benefits from Hypertension Therapy

CHICAGO -- Treating hypertension in patients age 80 and older is beneficial and safe, according to results of a multicenter trial with more than 3,800 participants.

« Previous Page — Next Page »

eNews & Updates

SPONSORSHIP: Upromise College Savings Plan

Login | The Arizona Pharmacist | Copyright © 2007-08 PharmAZy Services, LLC